Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
General Hepatology
•
Hepatology
Do you always consider ADPCKD or ARPCKD in a patient who is incidentally found to have liver and renal cysts?
Related Questions
How do you utilize Cystatin-C as a marker of renal dysfunction in patients with chronic liver disease?
What is your approach to a patient with an elevated alkaline phosphatase level, but negative PBC serologies and normal biliary imaging?
How do you approach a patient who has incidentally found liver and renal cysts?
Do you obtain liver biopsy to confirm the diagnosis of cirrhosis if cirrhotic liver morphology is noted on imaging?
Do you recommend the use of SGLT2 inhibitors to reduce the risk of liver cirrhosis in patients with Type 2 diabetes mellitus?
How do you incorporate palliative care specialists into the care of patients with chronic liver disease, especially those who may not be transplant candidates?
How would you approach a referral for concern for hemochromatosis with ferritin elevation but otherwise normal iron studies?
In what scenario do you continue surveillance of benign liver tumors, e.g., hepatocellular adenoma, in pregnant patients?
How do you counsel patients on the use and risks of alternative medications and supplements given how prevalent and easily accessible they are to the average person?
Who would be the right candidate in which TIPS placement would reduce portal hypertension to allow for a previously unattainable procedure?
